Literature DB >> 16210716

Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons.

Fehmida Visnegarwala1, Subhasree S Raghavan, Christopher M Mullin, Glenn Bartsch, Jack Wang, Donald Kotler, Cynthia L Gibert, Judith Shlay, Carl Grunfeld, Andrew Carr, Wafaa El-Sadr.   

Abstract

BACKGROUND: Data on associations of body composition with HIV disease characteristics are limited.
OBJECTIVE: We compared sex-specific associations between HIV disease characteristics and body composition in an racially-ethnically diverse cohort of antiretroviral-naive patients.
DESIGN: The study was a cross-sectional analysis of participants enrolled in a metabolic substudy of a multicenter trial. Regional fat was measured, and total body fat (TBF) was derived by using the Durnin-Womersley formula (DWF) and bioelectrical impedance analysis (BIA). Body cell mass (BCM) was measured by BIA.
RESULTS: Among 422 participants, 22% were women, 60% were African American, and 36% had prior AIDS-defining illnesses. Mean (+/-SD) age was 38.2 +/- 9.6 y, CD4+ count was 215 +/- 184 cells/mm3, and HIV RNA log10 was 5.0 +/- 0.8 copies/mL. On multivariate analysis, women with AIDS-defining illness had significantly (P < 0.005) lower regional body fat and TBF (BIA: -9.5 kg; DWF: -7.3 kg) but nonsignificantly lower BCM (-1.3 kg) than did women without such illnesses, whereas men with AIDS-defining illness had significantly (P < 0.005) lower BCM (-1.7 kg) but nonsignificantly lower TBF (BIA: -1.3 kg; DWF: -1.83 kg) than did men without such illnesses (P < 0.05 for sex differences in TBF). Significant negative associations of HIV RNA with BCM (-0.9 kg/log RNA; P = 0.03), TBF by BIA (-1.4 kg/log RNA; P = 0.05) and by DWF (-1.6 kg/log RNA; P = 0.01), and regional fat were observed in men only.
CONCLUSIONS: The effect of prior AIDS illness on body fat differed significantly between the sexes: women with prior AIDS-defining illness had significantly less fat than did women without such illnesses. An independent effect of HIV viremia on BCM and fat was seen in men. These distinctions may be due to inherent biological differences between the sexes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210716     DOI: 10.1093/ajcn/82.4.850

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  13 in total

1.  Viral mechanisms of adipose dysfunction: lessons from HIV-1 Vpr.

Authors:  N Agarwal; A Balasubramanyam
Journal:  Adipocyte       Date:  2014-10-30       Impact factor: 4.534

2.  Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.

Authors:  S S Martinez; A Campa; H Bussmann; S Moyo; J Makhema; F G Huffman; O D Williams; M Essex; R Marlink; M K Baum
Journal:  Br J Nutr       Date:  2016-04-18       Impact factor: 3.718

3.  HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR co-regulation.

Authors:  Neeti Agarwal; Dinakar Iyer; Sanjeet G Patel; Rajagopal V Sekhar; Terry M Phillips; Ulrich Schubert; Toni Oplt; Eric D Buras; Susan L Samson; Jacob Couturier; Dorothy E Lewis; Maria C Rodriguez-Barradas; Farook Jahoor; Tomoshige Kino; Jeffrey B Kopp; Ashok Balasubramanyam
Journal:  Sci Transl Med       Date:  2013-11-27       Impact factor: 17.956

4.  Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy.

Authors:  Shashi Shrivastav; Tomoshige Kino; Tshaka Cunningham; Takamasa Ichijo; Ulrich Schubert; Peter Heinklein; George P Chrousos; Jeffrey B Kopp
Journal:  Mol Endocrinol       Date:  2007-10-11

5.  HIV Wasting Syndrome in a Nigerian Failing Antiretroviral Therapy: A Case Report and Review of the Literature.

Authors:  Dimie Ogoina; Reginald O Obiako; Haruna M Muktar
Journal:  Case Rep Med       Date:  2010-12-27

6.  Physical activity and capacity at initiation of antiretroviral treatment in HIV patients in Ethiopia.

Authors:  M F Olsen; P Kæstel; M Tesfaye; A Abdissa; D Yilma; T Girma; C Mølgaard; D Faurholt-Jepsen; D L Christensen; S Brage; Å B Andersen; H Friis
Journal:  Epidemiol Infect       Date:  2014-06-24       Impact factor: 4.434

7.  Validity of impedance-based predictions of total body water as measured by 2H dilution in African HIV/AIDS outpatients.

Authors:  Adama Diouf; Agnès Gartner; Nicole Idohou Dossou; Dominique Alexis Sanon; Les Bluck; Antony Wright; Salimata Wade
Journal:  Br J Nutr       Date:  2008-10-10       Impact factor: 3.718

8.  Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES.

Authors:  Benjamin E Atkinson; Supriya Krishnan; Gary Cox; Todd Hulgan; Ann C Collier
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

9.  HIV-1 infection and the PPARγ-dependent control of adipose tissue physiology.

Authors:  Marta Giralt; Pere Domingo; Francesc Villarroya
Journal:  PPAR Res       Date:  2008-12-01       Impact factor: 4.964

10.  Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania.

Authors:  Henrik Friis; Nyagosya Range; John Changalucha; George Praygod; Kidola Jeremiah; Daniel Faurholt-Jepsen; Henrik Krarup; Christian Mølgaard; Åse Bengaard Andersen
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.